Ken Conway

Kenneth J. Conway is the Chief Executive Officer of Millennium Predictive Medicine, Inc. (MPMx), a subsidiary of Millennium Pharmaceuticals. He has been with the company since its inception in 1997, when he was recruited to lead its predictive medicine unit, focusing on diagnostics and pharmacogenomics.35

In his role, Conway oversees the development of innovative products that integrate genetic information to improve disease treatment and management. His leadership has been pivotal in establishing strategic alliances with major pharmaceutical companies to enhance drug discovery and development processes.12

Conway's background includes significant experience in the biotechnology sector, and he has held various leadership positions throughout his career, contributing to advancements in personalized medicine and predictive diagnostics.46